Bethesda, Maryland 20892

  • Pulmonary Disease

Purpose:

This study was developed in order for the professional-staff at the Pulmonary-Critical Care Medical Branch (PCCMB) of the National Heart, Lung, and Blood Institute to maintain their skills and increase their understanding of lung diseases. The study will permit PCCMB staff members to evaluate and treat patients with lung disease who do not meet the criteria for other research studies.


Study summary:

The professional staff in the Cardiovascular and Pulmonary Branch (CPB) needs to maintain their clinical skills and to enhance their clinical knowledge. The purpose of this protocol is to permit CPB staff to evaluate and treat patients with pulmonary disease who do not meet the criteria for existing research protocols.


Criteria:

- INCLUSION CRITERIA: Patients 8 years old and older with signs or symptoms of pulmonary disease of medical interest to the professional staff of CPB will be eligible for participation in this protocol. Only standard diagnostic procedures and conventional therapy will be performed. Patients will not be subjected to any research procedures. This protocol does not commit the NIH to medical or surgical treatment of protocol participants after discharge. Patients will be discharged to the referring physician. Consenting to pregnancy testing in minors of childbearing age: We will inform the minor during the assent process that for safety, we need to do a pregnancy test. She will also be told that if it is positive, we will counsel her and help her tell her parents. If the minor does not want to proceed she will be advised not to sign assent and her enrollment on this training protocol will end. EXCLUSION CRITERIA: Patients without symptoms of pulmonary disease will be excluded from this protocol.


Study is Available At:


Original ID:

970061


NCT ID:

NCT00001621


Secondary ID:

97-H-0061


Study Acronym:


Brief Title:

Evaluation and Treatment of Patients With Lung Disease Not Participating in Research


Official Title:

Evaluation and Treatment of Pulmonary Patients Not Participating in Research (Training Protocol)


Overall Status:

Completed


Study Phase:

N/A


Genders:

N/A


Minimum Age:

8 Years


Maximum Age:

99 Years


Quick Facts

Healthy Volunteers
Oversight Has DMC
Study Is FDA Regulated
Study Is Section 801
Has Expanded Access

Study Source:

National Institutes of Health Clinical Center (CC)


Oversight Authority:

United States: Federal Government


Reasons Why Stopped:


Study Type:

Observational


Study Design:


Number of Arms:

0


Number of Groups:

1


Total Enrollment:

280


Enrollment Type:

Actual


Overall Contact Information

Official Name:Joel Moss, M.D.
Principal Investigator
National Heart, Lung, and Blood Institute (NHLBI)

Study Dates

Start Date:February 12, 1997
Completion Date:September 25, 2020
Completion Type:Actual
Primary Completion Date:September 25, 2020
Primary Completion Type:Actual
Verification Date:September 2020
Last Changed Date:September 25, 2020
First Received Date:November 3, 1999

Study Outcomes

Outcome Type:Primary Outcome
Measure:to permit PB staff to evaluate and treat patients with pulmonary disease who do not meet the criteria for existing research protocols.
Time Frame:1 visit
Safety Issues:False
Description:The purpose of this protocol is to permit PB staff to evaluate and treat patients with pulmonary disease who do not meet the criteria for existing research protocols.

Study Interventions

There are no available Study Interventions

Study Arms

Study Arm Type:Other
Arm Name:1
Description:Pulmonary Patients

Study Agencies

Agency Class:NIH
Agency Type:Lead Sponsor
Agency Name:National Heart, Lung, and Blood Institute (NHLBI)

Samples and Retentions

Study Population: Patients with pulmonary disease who do not meet the criteria for existing research protocols.
Sample Method:Non-Probability Sample

Study References

There are no available Study References

Data Source: ClinicalTrials.gov

Date Processed: July 29, 2021

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


This study is not currently recruiting Study Participants. The form below is not enabled.